All articles by Staff Writer
Staff Writer
Roche’s IL-6 immunoassay wins CE mark for diagnosing neonatal sepsis
The Elecsys IL-6 immunoassay takes 18 minutes to run and is an early diagnostic marker for neonatal sepsis.
DuPont introduces higher-adhesion, low-cyclics silicone soft skin adhesive
DuPont™ Liveo™ MG 7-9960 Soft Skin Adhesive offers gentle skin adhesion in advanced wound dressings and wearables devices
4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection
In a significant financial milestone, Xlife Sciences AG invests CHF 23.3 million in 4D Lifetec AG, acquiring a 20% stake in the company. With the agreement signed today, Xlife Sciences is not only bringing in a direct cash investment, but also an AI software developed specifically for 4D Lifetec, which will massively expand the functionality of the 4D Lifetest™ in the field of digital health. The strategic investment marks a significant turning point in the healthcare industry as it combines financial strength with cutting-edge technology to revolutionize early cancer detection.
SUANFARMA announces a collaboration with Reyoung Pharmaceutical to expand the existing portfolio of anti-infective and antibacterial products
SUANFARMA, through its R&D division, celebrates the historic agreement reached with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients since 1966. Reyoung´s decades of experience as an exporter of products worldwide are perfectly aligned with SUANFARMA, which has been present in the pharmaceutical and nutritional ingredients market for 30 years.
Oncotech AI-powered diagnostic mobile cancer and diabetes screening technology Ophtascan™ gains distribution in Sri Lanka
Medical technology innovator, Oncotech Nordic AB, awarded CE marking in 2022 for its mobile health screening technology, Ophtascan™, will be distributed in Sri Lanka for the first time this autumn through a new partnership with the DiaPearl Group.
Neurologist Anthony Lang Presents Groundbreaking News on Parkinson’s Disease at World Congress of Neurology 2023
During a plenary lecture at the 26th World Congress of Neurology, Dr. Anthony Lang, professor of neurology and Jack Clark Chair for Parkinson’s Disease Research, University of Toronto, revealed a groundbreaking new model for identifying and studying Parkinson’s disease. This new approach will help researchers investigate biological aspects of the disease that may be detectable many years before symptoms begin to show.
BGI Genomics Combats Hepatitis in Ethiopia
Healthcare localization and standardization support the Belt and Road Initiative
Revvity and SCIEX Collaborate to Provide Innovative Neonatal Mass Spectrometry Solution
Offering combines Revvity’s market leading reagents with SCIEX precise innovative MS/MS for labs looking to expand newborn screening capabilities
bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic injury
bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE-marking of VIDAS® TBI (GFAP, UCH-L1), a blood test to support assessment of patients with mild traumatic brain injury (mTBI), based on a unique combination of brain biomarkers: GFAP and UCH-L1*. This accurate and objective tool can help reduce the number of unnecessary head Computed Tomography (CT) scans performed for mTBI patients and to decrease Emergency Department (ED) overcrowding by predicting the absence of acute intracranial lesions (ICL) following a head trauma.
Alpine Immune Sciences to Present Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late Breaker Poster Session at American Society of Nephrology Kidney Week 2023
The Company will host an investor event following the presentation after the close of market on Thursday, November 2nd